Castration-Resistant Prostate Carcinoma

Castration-Resistant Prostate Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

553 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 222
Recruiting: 123
Ph III recruiting: 12
Growth YoY: +25%
Industry share: 45%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (94)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03734653	Testosterone Therapy in Castration Resistant Prostate Cancer	completed	Early Phase 1	30	University of Colorado, DenverOTHER	1	Nov 6, 2025	clinicaltrials
NCT05725070	Phase 0/1 Study of 212Pb-NG001 in mCRPC	completed	Early Phase 1	3	ARTBIO Inc.INDUSTRY	1	Oct 6, 2023	clinicaltrials
NCT03071328